NCT01207635View on ClinicalTrials.gov

Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Breast Cancer
Interventions
PROCEDURE

Ductal Lavage Fluid Collection

Procedure of inserting a small catheter into the ductal openings in the nipple and washing out cells from inside the duct.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT01207635 - Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter